Supriya Lifescience Limited announced that Mr. Sreekant Sreedharan, General Manager – Sales & Marketing, has been granted bail by the sessions court. The proceedings relate to a matter under the Narcotic Drugs and Psychotropic Substances Act, 1985. Bail was granted on November 2, 2026, subject to conditions stipulated by the court. The company stated this development does not have a material impact on its operations.
Key Executive Granted Bail
Supriya Lifescience Limited has provided an update on ongoing judicial proceedings concerning one of its senior management personnel. Mr. Sreekant Sreedharan, who holds the position of General Manager – Sales & Marketing, has been granted bail by the Hon’ble Session Court.
The legal matter pertains to proceedings under the Narcotic Drugs and Psychotropic Substances Act, 1985. The bail was officially granted on November 2, 2026, with the court imposing specific conditions, as detailed in their order.
Company Statement on Impact
In its communication, the company emphasized that this development is not expected to have a material impact on Supriya Lifescience’s overall operations or business. The company has committed to keeping its stakeholders informed of any significant future developments related to this matter.
Source: BSE
